Baxter Recalls IV Solutions

April 10, 2015
Pharmaceutical Technology Editors

Baxter voluntarily recalls select lots of IV solutions due to possible particulate matter.

FDA reported on April 9, 2015 that Baxter International has voluntarily recalled select lots of intravenous (IV) solutions for possible particulate matter. The IV solutions include Sodium Chloride Injection, USP, indicated as a source of water and electrolytes and for use as a priming solution in hemodialysis procedures; Dextrose Injection, USP, indicated as a source of water and calories; and Lactated Ringer’s Injection, USP, indicated as a source of water and electrolytes, or as an alkalinizing agent. The recalled lots were distributed in the United States and Bermuda between Jan. 14, 2015 and March 5, 2015.

Baxter personnel discovered the particulates while performing routine maintenance and identified the particulates as material from a solution transmission system pump. The company has not yet received any adverse event reports or complaints.

A full list of recalled lots can be found on FDA’s website.

Source: FDA